cyclocreatine has been researched along with Uterine Cervical Neoplasms in 4 studies
cyclocreatine: structure given in first source
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, KJ | 3 |
| Vassallo, CD | 1 |
| Teicher, BA | 2 |
| Kaddurah-Daouk, R | 4 |
| Winslow, ER | 1 |
| Lillie, JW | 1 |
| O'Keefe, M | 1 |
| Valinski, H | 1 |
| Hamlin, HA | 1 |
| Varban, ML | 1 |
| Bergnes, G | 1 |
| Yuan, W | 1 |
| Khandekar, VS | 1 |
| O'Keefe, MM | 1 |
4 other studies available for cyclocreatine and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Colony-Forming Units Assay; Creatinine; Dru | 1995 |
Cell cycle studies of cyclocreatine, a new anticancer agent.
Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Cell Survival; Creatinine; Female; Humans; Phospho | 1994 |
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Transformation, Neoplastic; Creatine | 1993 |
Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Death; Colonic Neo | 1996 |